Weight loss associated with semaglutide use is linked to improved reproductive measures in polyendocrine metabolic ovarian syndrome: a proof-of-concept analysis.
- DOI
- 10.1016/j.fertnstert.2026.06.002
- Published
- 2026 Oct
- Container
- Fertility and sterility
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.fertnstert.2026.06.002,
title = {Weight loss associated with semaglutide use is linked to improved reproductive measures in polyendocrine metabolic ovarian syndrome: a proof-of-concept analysis.},
author = {Cree MG and Garcia-Reyes Y and Shapiro A and Carey G and Spencer K and Medrano GI and Faulkner C and Roth LP and Huguelet P and Caldwell AE and Catenacci VA and Brink HV and Santoro N},
year = {2026},
journal = {Fertility and sterility},
doi = {10.1016/j.fertnstert.2026.06.002},
url = {https://doi.org/10.1016/j.fertnstert.2026.06.002}
}RIS
TY - JOUR TI - Weight loss associated with semaglutide use is linked to improved reproductive measures in polyendocrine metabolic ovarian syndrome: a proof-of-concept analysis. AU - Cree MG AU - Garcia-Reyes Y AU - Shapiro A AU - Carey G AU - Spencer K AU - Medrano GI AU - Faulkner C AU - Roth LP AU - Huguelet P AU - Caldwell AE AU - Catenacci VA AU - Brink HV AU - Santoro N PY - 2026 JO - Fertility and sterility DO - 10.1016/j.fertnstert.2026.06.002 UR - https://doi.org/10.1016/j.fertnstert.2026.06.002 ER -
APA
MG, C., Y, G., A, S., G, C., K, S., GI, M., C, F., LP, R., P, H., AE, C., VA, C., HV, B., & N, S. (2026). Weight loss associated with semaglutide use is linked to improved reproductive measures in polyendocrine metabolic ovarian syndrome: a proof-of-concept analysis.. Fertility and sterility. https://doi.org/10.1016/j.fertnstert.2026.06.002
Source records
- pubmed · retrieved 2026-09-26T11:00:13.644Z